Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Open Medicine

formerly Central European Journal of Medicine

Editor-in-Chief: Darzynkiewicz, Zbigniew


IMPACT FACTOR 2018: 1.221

CiteScore 2018: 1.01

SCImago Journal Rank (SJR) 2018: 0.329
Source Normalized Impact per Paper (SNIP) 2018: 0.479

ICV 2017: 152.94

Open Access
Online
ISSN
2391-5463
See all formats and pricing
More options …
Volume 9, Issue 4

Issues

Volume 10 (2015)

Antibiotics in severe acute pancreatitis

Alejandro Serrablo / Luis Tejedor / Jessica Martínez
Published Online: 2014-07-19 | DOI: https://doi.org/10.2478/s11536-013-0281-3

Abstract

Acute pancreatitis (AP) is a local inflammatory response with systemic effects and an adverse evolution in 20% of cases. Its mortality rate is 5–10% in sterile and 15–40% in infected pancreatic necrosis. Infection is widely accepted as the main reason of death in AP. The evidence to enable a recommendation about antibiotic prophylaxis against infection of pancreatic necrosis is conflicting and difficult to interpret. Up to date, there is no evidence that supports the routine use of antibiotic prophylaxis in patients with severe AP. Treatment on demand seems to be the better option, avoiding excessive treatment and selection of bacterial. In infected acute pancreatitis, antibiotics of choice are imipenem, meronem or tigecycline in patients allergic to beta-lactams. Also fluconazole must be given in determinate clinical situations.

Keywords: Acute pancreatitis; Antibiotic prophylaxis; Antibiotic treatment

  • [1] Dervenis C, Johnson CD, Bassi C, et al. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol 1999; 25: 195–210 Google Scholar

  • [2] Beger H. G., Rau B., Isenmann R. et al. Antibiotic Prophylaxis in Severe Acute Pancreatitis. Pancreatology 2005; 5: 10–19 http://dx.doi.org/10.1159/000084485CrossrefGoogle Scholar

  • [3] Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg, 1993; 128: 586–590 http://dx.doi.org/10.1001/archsurg.1993.01420170122019Google Scholar

  • [4] Bassi C. Infected pancreatic necrosis. Int J Pancreatol, 1994; 16:1–10 Google Scholar

  • [5] Buchler MW, Gloor B, Muller CA, Friess H, Seller ChA, Uhl W. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg, 2000; 232: 619–26 http://dx.doi.org/10.1097/00000658-200011000-00001CrossrefGoogle Scholar

  • [6] Bradley E, Allen K. A prospective longitudinal study of observation versus surgical intervention in the management of necrotizing pancreatitis. Am J Surg 1991; 161: 19–25 http://dx.doi.org/10.1016/0002-9610(91)90355-HCrossrefGoogle Scholar

  • [7] Widdison A, Karanjia N. Pancreatic infection complicating acute pancreatitis. Br J Surg 1993; 80: 148–154 http://dx.doi.org/10.1002/bjs.1800800208CrossrefGoogle Scholar

  • [8] Büchler P, Reber H. Surgical approach in patients with acute pancreatitis. Is infected or sterile necrosis an indication-in whom should this be done, when and why? Gastroenterology Clinics of North America 1999; 28: 661–671 http://dx.doi.org/10.1016/S0889-8553(05)70079-0CrossrefGoogle Scholar

  • [9] Wyncoll D. The management of severe acute pancreatitis: an evidence-based review of the literature. Inpenetracióntensive Care Med 1999; 25: 146–156 http://dx.doi.org/10.1007/s001340050808CrossrefGoogle Scholar

  • [10] Fritz S, Hackert T, Hartwig W, et al. Bacterial translocation and infected pancreatic necrosis in acute necrotizing pancreatitis derives from small bowel rather than from colon Am J Surg 2010; 200(1): 111–117 http://dx.doi.org/10.1016/j.amjsurg.2009.08.019CrossrefGoogle Scholar

  • [11] Lowham A, Lavelle J, Leese T. Mortality from acute pancreatitis. Late septic deaths can be avoided but some early deaths still occur. Int J Pancreatol 1999; 25: 103–106 http://dx.doi.org/10.1385/IJGC:25:2:103CrossrefGoogle Scholar

  • [12] Tenner S, Sica G, Bank P, et al. Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology 1997; 113: 899–903 http://dx.doi.org/10.1016/S0016-5085(97)70185-9CrossrefGoogle Scholar

  • [13] Luiten E, Hop W, Lange J, et al. Differential prognosis of gram negative versus gram positive infected and sterile pancreatic necrosis: result of a randomized trial in patients with severe acute pancreatitis treated with adjuvant selective decontamination. Clin Infect Dis 1997; 25: 811–6 http://dx.doi.org/10.1086/515545CrossrefGoogle Scholar

  • [14] Delcenserie R, Yzet T, Ducroix J. Prophylactic antibiotics in treatment of severe acute alcoholic pancreatitis. Pancreas 1996; 13: 198–201 Google Scholar

  • [15] Mann D, Hershman M, Hittinger R et al. Multicentre audit of death from acute pancreatitis. Br J Surg 1994; 81: 890–893 http://dx.doi.org/10.1002/bjs.1800810632CrossrefGoogle Scholar

  • [16] Galvez S. Profilaxis antibiótica en la pancreatitis aguda grave. Clínicas de Medicina Intensiva. Fideco 1999; 339–349 Google Scholar

  • [17] Nordback I, Sand J, Saaristo R, et al. Early treatment with antibiotics reduces the need for surgery in acute necrotizing pancreatitis — a single-center randomized study. J Gastrointest Surg 2001; 5: 113–118 http://dx.doi.org/10.1016/S1091-255X(01)80021-4CrossrefGoogle Scholar

  • [18] Pederzoli P, Bassi C, Vesentini S, et al. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet 1993; 176:480–483 Google Scholar

  • [19] Isenmann R, Runzi M, Kron M, et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, doubleblind trial. Gastroenterology 2004; 126:997–1004 http://dx.doi.org/10.1053/j.gastro.2003.12.050CrossrefGoogle Scholar

  • [20] Sainio V, Kemppainen E, Puolakkainen P, et al. Early antibiotic treatment in acute necrotising pancreatitis. Lancet 1995; 346:663–667 http://dx.doi.org/10.1016/S0140-6736(95)92280-6CrossrefGoogle Scholar

  • [21] Schwarz M, Isenmann R, Meyer H, et al. Antibiotic use in necrotizing pancreatitis. Results of a controlled study. Dtsch Med Wochenschr 1997; 122:356–361 http://dx.doi.org/10.1055/s-2008-1047621CrossrefGoogle Scholar

  • [22] Bassi C, Larvin M, Villatoro E. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis (Cochrane Methodology Review). Chichester: UK, John Wiley & Sons Ltd, The Cochrane Library, issue 4, 2003 Google Scholar

  • [23] Howes R, Zuidema G, Cameron J. Evaluation of prophylactic antibiotics in acute pancreatitis. J Surg Res 1975; 18: 197–200 http://dx.doi.org/10.1016/0022-4804(75)90016-5CrossrefGoogle Scholar

  • [24] Craig RM, Dordal E, Myles L. The use of ampicillin in acute pancreatitis. Ann Intern Med 1975; 83:831–832 http://dx.doi.org/10.7326/0003-4819-83-6-831CrossrefGoogle Scholar

  • [25] Finch W, Sawyers J, Schenker S. A prospective study to determine the efficacy of antibiotics in acute pancreatitis. Ann Surg 1976; 183: 667–671 http://dx.doi.org/10.1097/00000658-197606000-00008CrossrefGoogle Scholar

  • [26] Bassi C, Falconi M, Talamini G, et al. Controlled clinical trial of pefloxacine versus imipenem in severe acute pancreatitis. Gastroenterology. 1998; 115: 1513–1517 http://dx.doi.org/10.1016/S0016-5085(98)70030-7CrossrefGoogle Scholar

  • [27] Luiten EJ, Hop WC, Lange JF, et al. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 1995; 222:57–65 http://dx.doi.org/10.1097/00000658-199507000-00010CrossrefGoogle Scholar

  • [28] Golub R, Siddigi F, Pohl D. Role of antibiotics in acute pancreatitis: A meta-analysis. Gastrointest Surg 1998; 2: 496–503 http://dx.doi.org/10.1016/S1091-255X(98)80048-6CrossrefGoogle Scholar

  • [29] Johnson C. Antibiotic prophylaxis in severe acute pancreatitis. Br J Surg 1996; 83: 883–884 http://dx.doi.org/10.1002/bjs.1800830703CrossrefGoogle Scholar

  • [30] Moody F, Haley-Russell D, Muncy D. Intestinal transit and bacterial translocation in obstructive pancreatitis. Dig Dis Sci 1995; 40: 1798–1804 http://dx.doi.org/10.1007/BF02212705CrossrefGoogle Scholar

  • [31] Powell J, Miles R, Siriwardena A. Review: Antibiotic prophylaxis in the initial management of severe acute pancreatitis. Br J Surg 1998; 85: 582–587 http://dx.doi.org/10.1046/j.1365-2168.1998.00767.xCrossrefGoogle Scholar

  • [32] Büchler M, Malfertheiner P, Frieβ H, et al. Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology 1992; 103: 1902–1908 Google Scholar

  • [33] Kochhar R, Ahammed SK, Chakrabarti A, Ray P, Sinha SK, Dutta U, Wig JD, Singh K. Prevalence and outcome of fungal infection in patients with severe acute pancreatitis. J Gastroenterol Hepatol. 2009 May; 24(5): 743–747 http://dx.doi.org/10.1111/j.1440-1746.2008.05712.xCrossrefGoogle Scholar

  • [34] De Waele JJ, Vogelaers D, Blot S, Colardyn F. Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy. Clin Infect Dis. 2003 Jul 15; 37(2): 208–213 http://dx.doi.org/10.1086/375603CrossrefGoogle Scholar

  • [35] Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858–873 http://dx.doi.org/10.1097/01.CCM.0000117317.18092.E4CrossrefGoogle Scholar

  • [36] Kochhar R, Noor MT, Wig J. Fungal infections in severe acute pancreatitis. J Gastroenterol Hepatol. 2011 Jun; 26(6): 952–959 http://dx.doi.org/10.1111/j.1440-1746.2011.06685.xCrossrefGoogle Scholar

  • [37] Dellinger EP, Tellado JM, Soto NE, Ashley SW, Barie PS, Dugernier T, Imrie CW, Johnson CD, Knaebel HP, Laterre PF, et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Ann Surg. 2007; 245:674–683 http://dx.doi.org/10.1097/01.sla.0000250414.09255.84CrossrefGoogle Scholar

  • [38] Brattstrôm C, Malmborg AS, Tyden G. Penetration of imipenem into human pancreatic juice following single intravenous dose administration. Chemotherapy. 1989; 35: 83–87 http://dx.doi.org/10.1159/000238652CrossrefGoogle Scholar

  • [39] Buchler M, Malfertheiner P, Friess H, et al. Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology. 1992; 103(6): 1902–1908 Google Scholar

  • [40] Minelli EB, Benini A, Bassi C, Abbas H, Falconi M, Locatelli F, de Marco R, Pederzoli P. Antimicrobial activity of human pancreatic juice and its interaction with antibiotics. Antimicrob Agents Chemother. 1996 Sep; 40(9): 2099–2105 PubMedGoogle Scholar

  • [41] Wittau M, Wagner E, Kaever V, Koal T, Henne-Bruns D, Isenmann R. Intraabdominal tissue concentration of ertapenem. J Antimicrob Chemother. 2006 Feb; 57(2): 312–316 http://dx.doi.org/10.1093/jac/dki459CrossrefGoogle Scholar

  • [42] Brattström C, Malborg AS, Tydén G. Penetration of ciprofloxacin and ofloxacin into pancreatic juice. Chemioterapia. 1987; 6: 295–297 Google Scholar

  • [43] Pederzoli, P., M. Falconi, C. Bassi, S. Vesentini, F. Orcalli, F. Scaglione, A. Messori, and N. Martini. Ciprofloxacin penetration in pancreatic juice. Chemotherapy. 1987; 33: 397–401 http://dx.doi.org/10.1159/000238527CrossrefGoogle Scholar

  • [44] Isenmann R, Friess H, Schlegel P, Fleischer K, Buchler MW. Penetration of ciprofloxacin into the human pancreas. Infection. 1994; 22: 343–346 http://dx.doi.org/10.1007/BF01715543CrossrefGoogle Scholar

  • [45] Adam U, Herms S, Werner U, Strubelt H, Makowiec F, Hopt UT, et al. The penetration of ciprofloxacin into human pancreatic and peri pancreatic necrosis in acute necrotizing pancreatitis. Infection. 2001; 29:326–331 http://dx.doi.org/10.1007/s15010-001-1158-yCrossrefGoogle Scholar

  • [46] Malmborg AS, Brattström C, Tydén G. Penetration of pefloxacin into human allograft pancreatic juice. J Antimicrob Chemother. 1990; 25:393–397 http://dx.doi.org/10.1093/jac/25.3.393CrossrefGoogle Scholar

  • [47] Bertazzoni ME, Benini A, Muner A, Bassi C, Abbas H, Pederzoli P. Pefloxacin penetration into human necrotic pancreatic tissue. J Antimicrob Chemother. 1996; 38: 237–243 http://dx.doi.org/10.1093/jac/38.2.237CrossrefGoogle Scholar

  • [48] Wacke R, Forster S, Adam U, Mundkowski RG, Klar E, Hopt UT, et al. Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose. J Antimicrob Chemother. 2006; 58: 994–999 http://dx.doi.org/10.1093/jac/dkl353CrossrefGoogle Scholar

  • [49] Wallace JR, Cushing RD, Bawdon RE, Sugawa C, Lucas CE, Ledgerwood AM. Assessment of antimicrobial penetrance into the pancreatic juice in humans. Surg Gynecol Obstet. 1986; 162: 313–316 Google Scholar

  • [50] Buchler M, Malfertheiner P, Friess H, Bittner R, Vanek E, Schlegel P et al. The penetration of antibiotics into human pancreas. Infection. 1989; 17:20–25 http://dx.doi.org/10.1007/BF01643494CrossrefGoogle Scholar

  • [51] Brattström C, Malmborg AS, Tydén G. Penetration of clindamycin, cefoxitin, and piperacillin into pancreatic juice in man. Surgery. 1988 May; 103(5): 563–567 Google Scholar

  • [52] Martin C, Cottin A, Francois-Godfroy N, Mallet MN, Martin A, Sastre B, et al. Concentrations of prophylactic ceftriaxone in abdominal tissues during pancreatic surgery. J Antimicrob Chemother. 1997; 40: 445–448 http://dx.doi.org/10.1093/jac/40.3.445CrossrefGoogle Scholar

  • [53] Drewelow B, Koch K, Otto C, Franke A, Riethling AK. Penetration of ceftazidime into human pancreas. Infection. 1993; 21:229–234 http://dx.doi.org/10.1007/BF01728896CrossrefGoogle Scholar

  • [54] Delcenserie R, Dellion-Lozinguez MP, Yzet T, Lepointe B, Hary L, Badoui R et al. Pancreatic concentrations of cefepime. J Antimicrob Chemother. 2001; 47: 711–713 http://dx.doi.org/10.1093/jac/47.5.711CrossrefGoogle Scholar

  • [55] Wallace JR, Johnson J, Lucas CE, Cushing R, Ledgerwood AM, Sugawa C. Assessment of pancreatic ductal penetration of antibiotics. Am Surg. 1984; 50(12): 666–667 Google Scholar

  • [56] Shrikhande S, Friess H, Issenegger C, Martignoni ME, Yong H, Gloor B, Yeates R, Kleeff J, Büchler MW. Fluconazole penetration into the pancreas. Antimicrob Agents Chemother. 2000 September; 44(9): 2569–2571 http://dx.doi.org/10.1128/AAC.44.9.2569-2571.2000CrossrefGoogle Scholar

  • [57] Villatoro E, Mulla M, Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database of Systematic Reviews 2010, Issue 5. Art. No: CD002941. DOI: 10.1002/14651858.CD002941. pub 3 CrossrefGoogle Scholar

  • [58] Heinrich S, Schäfer M, Rousson V, Clavien PA. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg. 2006 Feb; 243(2): 154–168 http://dx.doi.org/10.1097/01.sla.0000197334.58374.70CrossrefGoogle Scholar

  • [59] Mazaki T, Ishii Y, Takayama T. Meta-analysis of prophylactic antibiotic use in acute necrotizing pancreatitis. Br J Surg. 2006 Jun; 93(6): 674–684 http://dx.doi.org/10.1002/bjs.5389CrossrefGoogle Scholar

  • [60] Xiong GS, Wu SM, Wang ZH. Role of prophylactic antibiotic administration in severe acute pancreatitis: a meta-analysis. Med Princ Pract. 2006; 15(2): 106–110 http://dx.doi.org/10.1159/000090913CrossrefGoogle Scholar

  • [61] Hart PA, Bechtold ML, Marshall JB, Choudhary A, Puli SR, Roy PK. Prophylactic antibiotics in necrotizing pancreatitis: a meta-analysis. South Med J. 2008 Nov; 101(11): 1126–1131 http://dx.doi.org/10.1097/SMJ.0b013e31817ecbdaCrossrefGoogle Scholar

  • [62] Bai Y, Gao J, Zou DW, Li ZS. Prophylactic antibiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2008; 103(1): 104–110 http://dx.doi.org/10.1111/j.1572-0241.2007.01575.xCrossrefGoogle Scholar

  • [63] Xu T, Cai Q. Prophylactic antibiotic treatment in acute necrotizing pancreatitis: results from a metaanalysis. Scand J Gastroenterol. 2008; 43(10): 1249–1258 http://dx.doi.org/10.1080/00365520802130175CrossrefGoogle Scholar

  • [64] Jafri NS, Mahid SS, Idstein SR, Hornung CA, Galandiuk S. Antibiotic prophylaxis is not protective in severe acute pancreatitis: a systematic review and meta-analysis. Am J Surg. 2009 Jun; 197(6): 806–813 http://dx.doi.org/10.1016/j.amjsurg.2008.08.016CrossrefGoogle Scholar

  • [65] Jiang K, Huang W, Yang XN, Xia Q. Present and future of prophylactic antibiotics for severe acute pancreatitis. World J Gastroenterol. 2012 Jan; 2118(3): 279–284 http://dx.doi.org/10.3748/wjg.v18.i3.279CrossrefGoogle Scholar

  • [66] Wittau M, Mayer B, Scheele J, Henne-Bruns D, Dellinger EP, Isenmann R. Systematic review and meta-analysis of antibiotic prophylaxis in severe acute pancreatitis. Scandinavian Journal of Gastroenterology, 2011; 46: 261–270 http://dx.doi.org/10.3109/00365521.2010.531486CrossrefGoogle Scholar

  • [67] Ignatavicius P, Vitkauskiene A, Pundzius J, Dambrauskas Z, Barauskas G. Effects of prophylactic antibiotics in acute pancreatitis. HPB (Oxford). 2012 Jun; 14(6): 396–402 http://dx.doi.org/10.1111/j.1477-2574.2012.00464.xGoogle Scholar

  • [68] Segarra-Newnham M, Hough A. Antibiotic prophylaxis in acute necrotizing pancreatitis revisited. Ann Pharmacother. 2009 Sep; 43(9): 1486–1495 http://dx.doi.org/10.1345/aph.1M153CrossrefGoogle Scholar

  • [69] Beger HG, Gansauge F, Poch B, Schwarz M. The use of antibiotics for acute pancreatitis: is there a role? Curr Infect Dis Rep. 2009 Mar; 11(2): 101–107 http://dx.doi.org/10.1007/s11908-009-0015-5CrossrefGoogle Scholar

About the article

Published Online: 2014-07-19

Published in Print: 2014-08-01


Citation Information: Open Medicine, Volume 9, Issue 4, Pages 565–573, ISSN (Online) 2391-5463, DOI: https://doi.org/10.2478/s11536-013-0281-3.

Export Citation

© 2014 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Leidy Juliana Puerto Horta, Rolando Medina Rojas, Luis Ramiro Nuñez Romero, Héctor Conrado Jiménez Sánchez, Justo Germán Olaya Ramírez, Juan Felipe San Juan, Sergio Andrés Puerto Horta, Carlos Mauricio Martínez Montalvo, and María Mónica Medina Cabrera
Revista Colombiana de Gastroenterología, 2019, Volume 34, Number 1, Page 10

Comments (0)

Please log in or register to comment.
Log in